Synapse - Phillip Wong

Search Within

Phillip Wong

Results (80)

Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma

Journal Article

Movva, S.; Seier, K.; Bradic, M.; Charalambous, K.; Rosenbaum, E.; Kelly, C. M.; Cohen, S. M.; Hensley, M. L.; Avutu, V.; Banks, L. B.; more...
Journal for ImmunoTherapy of Cancer (2025)

Fulltext@MSK | Save

Olaparib and durvalumab in patients with DNA damage repair alterations and biochemically recurrent prostate cancer

Journal Article

Autio, K. A.; McHugh, D. J.; Rathkopf, D. E.; Xiao, H.; Merugu, S.; Wong, P.; Jan, M.; Dorff, T. B.; Heath, E. I.; Scher, H. I.
Journal of Immunotherapy and Precision Oncology (2025)

Fulltext@MSK | Save

Characterizing the immune effects of enfortumab vedotin (EV) on peripheral blood mononuclear cells (PBMCs) in metastatic urothelial cancer patients (mUC)

Meeting Abstract

Gupta, A.; Sevilla, C.; Pihlstrom, N. L.; Liang, S.; Regazzi, A. M.; McCoy, A. S.; Maher, C. A.; Wong, P.; Ahmed, F.; Funt, S. A.; more...
Journal of Clinical Oncology (2025)

Fulltext@MSK | Save

Combining a WT1 vaccine (Galinpepimut-S) with checkpoint inhibition (nivolumab) in patients with WT1–expressing diffuse pleural mesothelioma: A phase 1 study

Journal Article

Agrawal, P.; Offin, M.; Lai, V.; Ginsberg, M. S.; Adusumilli, P. S.; Rusch, V. W.; Sauter, J. L.; Ho, T.; Wong, P.; Zauderer, M. G.
JTO Clinical and Research Reports (2025)

Fulltext@MSK | Save

Peripheral blood (PB) T cell phenotype and tumor microenvironment (TME) subtype are independently associated with immune checkpoint blockade (ICB) outcomes in sarcomas

Meeting Abstract

Rosenbaum, E.; Ehrich, F.; Bradic, M.; Kelly, C. M.; Movva, S.; Chan, J.; Chi, P.; Banks, L.; Dickson, M.; Keohan, M. L.; more...
Annals of Oncology (2024)

Fulltext@MSK | Save

Systemic immunological changes after yttrium-90 radioembolization: A pilot prospective observational study — Clinical insights

Journal Article

Kitsel, Y.; Petre, E. N.; Wong, P.; Sotirchos, V.; Vakiani, E.; Dimopoulos, P. M.; Ganesh, K.; Rousseau, B.; Sofocleous, C. T.
CardioVascular and Interventional Radiology (2024)

Fulltext@MSK | Save

Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer

Journal Article

Tsimberidou, A. M.; Alayli, F. A.; Okrah, K.; Drakaki, A.; Khalil, D. N.; Kummar, S.; Khan, S. A.; Hodi, F. S.; Oh, D. Y.; Cabanski, C. R.; more...
Journal of Experimental Medicine (2024)

Fulltext@MSK | Save

Correlation of peripheral blood monocytic myeloid-derived suppressor cells (M-MDSC) and T-cell receptor (TCR) dynamics with clinical outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with nivolumab (NIVO)

Meeting Abstract

Gupta, A.; Whiting, K.; Keegan, N. M.; Schmalz, J.; Al-Ahmadie, H. A.; Regazzi, A. M.; McCoy, A. S.; Maher, C. A.; Iyer, G.; Rosenberg, J. E.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Combining a WT1 cancer vaccine (galinpepimut-S) with checkpoint inhibition (nivolumab) in patients with WT1-expressing diffuse pleural mesothelioma (DPM): A phase I study

Meeting Abstract

Agrawal, P.; Offin, M.; Ginsberg, M. S.; Adusumilli, P. S.; Rusch, V. W.; Sauter, J. L.; Ho, T.; Wong, P.; Zauderer, M. G.
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Phase I trial of CRD3874-SI, a systemically administered STING agonist, in patients with advanced solid tumors

Meeting Abstract

Kelly, C. M.; Avutu, V.; Banks, L. B.; Chan, J. E.; Chi, P.; Clark, C.; Counihan, O.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save